Sea Mild Biotechnology Co., Ltd.
7516.TWO is overvalued
TWO · Consumer Defensive
FAIR PRICE
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
$8.10
MARKET PRICE
$3.93
FAIR PRICE
$4.17
MARGIN
COMMUNITY BUY ZONE
UNLOCKS AT 10
Where does the market buy 7516.TWO?
No one has priced 7516.TWO yet — be the first. Every investor sets the maximum price they'd still buy at; together that maps the community buy zone.
COMMUNITY MEDIAN
▓▓▓▓▓
BUYERS AT TODAY'S PRICE
▓▓ %
0/10 INVESTORS · 10 MORE TO UNLOCK
METRICS
NOW AVAILABLE
Get notified when 7516.TWO's fair price changes
Push notifications when 7516.TWO's valuation shifts. Available on iOS and Android.
FPI RATING
Consistent growth trajectory, but below-average fundamental quality and elevated debt levels.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$3.14
Fair price × 0.80
DISTANCE
61.2%
Price to entry level
At the current price of $8.10, 7516.TWO trades 61.2% above the conservative entry level of $3.14. This entry level represents a 20% margin of safety below the calculated fair price of $3.93 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
SYNCING FEED ▌
P/E RATIO HISTORY
SYNCING FEED ▌
METHODOLOGY
How we calculate 7516.TWO's fair price
Sea Mild Biotechnology Co., Ltd.'s fair price of $3.93 is derived from a blended model that combines DCF analysis (50%), relative valuation against Consumer Defensive peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $8.10, 7516.TWO trades 51.5% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting 7516.TWO's risk profile.
RELATIVE · 30%
Comparing 7516.TWO's valuation multiples against Consumer Defensive peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for 7516.TWO, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate 7516.TWO's fair value with your own inputs.
7516.TWO DCF Calculator
Pre-filled with 7516.TWO's real free cash flow and share count — set your own growth and discount rate to calculate intrinsic value.
Graham Number
Enter 7516.TWO's EPS and book value to see the maximum price Benjamin Graham would pay for this stock.
P/E Ratio Calculator
Check how much investors pay per dollar of 7516.TWO's earnings and compare it against sector benchmarks.
EV/EBITDA Calculator
Compare 7516.TWO against peers on a debt-adjusted basis using enterprise value and EBITDA.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for 7516.TWO.
Explore on BuliosFAQ
What is the fair price of 7516.TWO?+
Based on our blended model combining DCF analysis (50%), relative valuation against Consumer Defensive peers (30%), and analyst consensus (20%), the fair price for Sea Mild Biotechnology Co., Ltd. is $3.93. At the current market price of $8.10, 7516.TWO trades 51.5% above its calculated fair value.
Is 7516.TWO overvalued or undervalued?+
Sea Mild Biotechnology Co., Ltd. is currently overvalued based on our valuation model. The stock trades at $8.10, which is 51.5% above the fair price of $3.93. The P/E ratio of 19.8x is a key metric in the valuation.
What is the margin of safety for 7516.TWO?+
With a 20% margin of safety applied to the fair price of $3.93, the conservative entry level for 7516.TWO is $3.14. At the current market price of $8.10, the stock trades 61.2% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is 7516.TWO's fair price updated?+
We update fair price calculations for 7516.TWO daily after market close. The current fair price of $3.93 incorporates the latest market data and sector multiples.
What factors affect 7516.TWO's fair price calculation?+
7516.TWO's fair price of $3.93 is derived from DCF analysis (50% weight), relative valuation against Consumer Defensive peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 19.8x, ROE of 7.6%.
Is 7516.TWO a good buy right now?+
At $8.10, 7516.TWO trades 51.5% above our fair value estimate of $3.93. The stock is currently overvalued. ROE stands at 7.6% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does 7516.TWO pay dividends?+
7516.TWO does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.